News items related to: Ukraine
-
Vera: HIV targets won’t be met without gender equality and accessible treatment
On the day that new research is published, showing that countries are being overcharged by $34 billion a year for HIV drugs, Vera Varyga,...
-
Ukraine: 100% LIFE opposes patent on TB drug for children
Our campaign partner in Ukraine, 100% LIFE, has submitted the first patent opposition on bedaquiline in the Eastern Europe and Central...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
A luxury travel writer’s journey through Ukraine’s health system as a TB patient
An interview with Krystyna Rivera, communication officer at 100% LIFE, Ukraine. Interview by Gemma Taylor. As a travel journalist, Krystyna...
-
Journalists’ training in Ukraine: Reporting on barriers to treatment
Earlier this month (5 September), journalists joined an event arranged by our partner, 100% Life, in Kyiv, Ukraine, for training...
-
Supporting more people to challenge injustices: A day in the life of a treatment activist
What got you interested in treatment activism to start with? Someone in my family was struggling to access life-saving medicines....
-
Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
On 28 May 2019, 100 Percent Life (the Network) submitted an opposition to the Ukrainian Patent and Trademark Office against...
-
Action against AbbVie. Money that could treat HIV patients ‘goes up in smoke’ in Kiev
Activists gathered outside a Kiev Court to highlight the huge amount of money being wasted on an overpriced drug, due...
-
Patent on Hep C drug rejected in Ukraine: Price of sofosbuvir will significantly reduce
The Ministry of Economic Development and Trade of Ukraine (MEDT) refused to grant the pharmaceutical company Gilead a patent for...
-
Patent law amendments approved by the Government of Ukraine
Stricter patent law amendments, proposed by our partner, the All-Ukrainian Network of People Living with HIV/AIDS (the Network), have been...
